Page last updated: 2024-11-01

nomifensine and Hemiplegia, Crossed

nomifensine has been researched along with Hemiplegia, Crossed in 1 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piacentini, F1
Prati, R1
Prosdocimo, M1

Other Studies

1 other study available for nomifensine and Hemiplegia, Crossed

ArticleYear
[Use of antidepressive drugs in rehabilitation].
    La Clinica terapeutica, 1983, Nov-30, Volume: 107, Issue:4

    Topics: Depression; Female; Hemiplegia; Humans; Isoquinolines; Male; Nomifensine; Sleep Wake Disorders

1983